Intravenous doxycycline (Vibramycin I.V.): a clinical evaluation.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria; D003967:Diarrhea / Q000139:chemically induced; D004318:Doxycycline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007275:Injections, Intravenous; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010689:Phlebitis / Q000139:chemically induced; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced; D014552:Urinary Tract Infections / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced
D004318:Doxycycline